193 related articles for article (PubMed ID: 35422572)
1. Multi-factorial Mechanism Behind COVID-19 Related Thrombosis.
Ali EW; Ibrahim IK
Med Arch; 2022 Feb; 76(1):62-65. PubMed ID: 35422572
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis.
Płazak W; Drabik L
Clin Rheumatol; 2023 Oct; 42(10):2691-2702. PubMed ID: 36622519
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
Ahmed S; Zimba O; Gasparyan AY
Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study.
Najim M; Rahhal A; Khir F; Aljundi AH; Abu Yousef S; Ibrahim F; Amer A; Mohamed AS; Saleh S; Alfaridi D; Mahfouz A; Alyafei S; Howady F; Khatib M; Alemadi SA
Rheumatol Int; 2021 Jul; 41(7):1243-1252. PubMed ID: 33954813
[TBL] [Abstract][Full Text] [Related]
5. Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
Siguret V; Voicu S; Neuwirth M; Delrue M; Gayat E; Stépanian A; Mégarbane B
Thromb Res; 2020 Nov; 195():74-76. PubMed ID: 32663703
[TBL] [Abstract][Full Text] [Related]
6. Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection.
Boccatonda A; Campello E; Simion C; Simioni P
Expert Rev Hematol; 2023; 16(12):1035-1048. PubMed ID: 38018136
[TBL] [Abstract][Full Text] [Related]
7. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019.
Wada H; Shiraki K; Shimpo H; Shimaoka M; Iba T; Suzuki-Inoue K
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175680
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19.
Hollerbach A; Müller-Calleja N; Pedrosa D; Canisius A; Sprinzl MF; Falter T; Rossmann H; Bodenstein M; Werner C; Sagoschen I; Münzel T; Schreiner O; Sivanathan V; Reuter M; Niermann J; Galle PR; Teyton L; Ruf W; Lackner KJ
J Thromb Haemost; 2021 Sep; 19(9):2335-2347. PubMed ID: 34242469
[TBL] [Abstract][Full Text] [Related]
10. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium.
Gorog DA; Storey RF; Gurbel PA; Tantry US; Berger JS; Chan MY; Duerschmied D; Smyth SS; Parker WAE; Ajjan RA; Vilahur G; Badimon L; Berg JMT; Cate HT; Peyvandi F; Wang TT; Becker RC
Nat Rev Cardiol; 2022 Jul; 19(7):475-495. PubMed ID: 35027697
[TBL] [Abstract][Full Text] [Related]
11. Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies.
Cristiano A; Fortunati V; Cherubini F; Bernardini S; Nuccetelli M
Clin Rheumatol; 2021 Jul; 40(7):2939-2945. PubMed ID: 33464429
[TBL] [Abstract][Full Text] [Related]
12. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation.
Wang C; Yu C; Jing H; Wu X; Novakovic VA; Xie R; Shi J
Front Cell Infect Microbiol; 2022; 12():861703. PubMed ID: 35449732
[TBL] [Abstract][Full Text] [Related]
13. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
[TBL] [Abstract][Full Text] [Related]
14. A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes' interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19.
Ding J; Hostallero DE; El Khili MR; Fonseca GJ; Milette S; Noorah N; Guay-Belzile M; Spicer J; Daneshtalab N; Sirois M; Tremblay K; Emad A; Rousseau S
PLoS Comput Biol; 2021 Mar; 17(3):e1008810. PubMed ID: 33684134
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review.
Riou M; Coste F; Meyer A; Enache I; Talha S; Charloux A; Reboul C; Geny B
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732160
[TBL] [Abstract][Full Text] [Related]
16. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism.
Margaglione M; Brancaccio V; De Lucia D; Martinelli I; Ciampa A; Grandone E; Di Minno G
Chest; 2000 Nov; 118(5):1405-11. PubMed ID: 11083693
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis in COVID-19.
Hanff TC; Mohareb AM; Giri J; Cohen JB; Chirinos JA
Am J Hematol; 2020 Dec; 95(12):1578-1589. PubMed ID: 32857878
[TBL] [Abstract][Full Text] [Related]
18. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
20. Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?
Castillo-Martínez D; Torres Z; Amezcua-Guerra LM; Pineda C
Clin Rheumatol; 2021 Jul; 40(7):3015-3019. PubMed ID: 33826045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
